Pharmacology & ToxicologyJournal of the American Heart AssociationPeer-reviewed
A randomized, controlled, two-center preclinical trial assessing the efficacy of a new benzodiazepine-dihydropyridine hybrid molecule (JM-20) in rodent models of ischemic stroke
Jeney Ramírez-Sánchez, André Rex, Sarah McCann…·Ulrich Dirnagl
This paper reports a two-center preclinical trial of JM-20, a benzodiazepine-dihydropyridine hybrid, showing modest neuroprotective effects in some rodent models of ischemic stroke but not in others.